Literature DB >> 8083722

Tamoxifen and chemotherapy in the treatment of metastatic melanoma: are there other possible mechanisms explaining their potentiation?

G Gasparini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8083722     DOI： 10.1200/JCO.1994.12.9.1994

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.

Authors:  N Harbeck; P Dettmar; C Thomssen; U Berger; K Ulm; R Kates; H Höfler; F Jänicke; H Graeff; M Schmitt
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

2.  Expression of c-erbB3 protein in primary breast carcinomas.

Authors:  R Naidu; M Yadav; S Nair; M K Kutty
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.